H

HuMab

0 employees

HuMab is developing SynThese, a fully human antibody discovery transgenic mouse platform for developing novel antibody therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Therapeutics

Biopharma

Medical

Health Care

Date founded

2018

Funding rounds raised

H

HuMab raised undisclosed on July 1, 2018

Investors: TIPS Town

FAQ